We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. ATLANTA — Patients in the RE-SONATE trial who extended ...
Patients with multiple myeloma are at increased risk for blood clots, especially in the first 6 to 12 months after treatment initiation. Many physicians advise no more than a daily aspirin to avoid ...
Phase I Dose Escalation, Pharmacokinetic and Pharmacodynamic Study of Naptumomab Estafenatox Alone in Patients With Advanced Cancer and With Docetaxel in Patients With Advanced Non–Small-Cell Lung ...
Paul P. Dobesh, PharmD, explained that the approval of betrixaban was important for several reasons: VTE events continue to occur during hospitalization and following discharge, despite the standard ...
Venous thromboembolism rates among patients with advanced non-small cell lung cancer varied by treatment type, according to retrospective study results. Patients treated with platinum-based ...
December 19, 2011 (San Diego, CA) — Data from the RECOVER II study confirms the safety and efficacy of dabigatran (Pradaxa, Boehringer Ingelheim) when compared with warfarin for the treatment of ...
Peripheral blood samples were collected from all patients before treatment and DD levels were measured. Blood samples were drawn from an antecubital vein by atraumatic puncture into plastic tubes ...
The VTE rate ratios were significantly greater for all forms of hormonal contraception, except for progestin-only pills, compared with non-use. Venous thromboembolism (VTE) continues to be a risk ...
Abbreviations: VTE, venous thromboembolism; AL, acute leukemia; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; APL, acute promyelocytic leukemia. VTE ...
In patients with a first VTE provoked by strong triggers, there is no role for thrombophilia testing. In young patients with VTE provoked by weak factors (minor surgery or prolonged air travel), ...
In contrast to the elevated risk of venous thromboembolism (VTE) observed in patients hospitalized with COVID-19, outpatients with SARS-CoV-2 infection do not appear to carry a greater risk, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback